BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9987446)

  • 1. Performance of the AutoPap primary screening system at Jefferson University Hospital.
    Bibbo M; Hawthorne C
    Acta Cytol; 1999; 43(1):27-9. PubMed ID: 9987446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does use of the AutoPap assisted primary screener improve cytologic diagnosis?
    Bibbo M; Hawthorne C; Zimmerman B
    Acta Cytol; 1999; 43(1):23-6. PubMed ID: 9987445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A feasibility study of the AutoPap system location-guided screening.
    Lee JS; Kuan L; Oh S; Patten FW; Wilbur DC
    Acta Cytol; 1998; 42(1):221-6. PubMed ID: 9479344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AutoPap system for primary screening in cervical cytology. Comparing the results of a prospective, intended-use study with routine manual practice.
    Wilbur DC; Prey MU; Miller WM; Pawlick GF; Colgan TJ
    Acta Cytol; 1998; 42(1):214-20. PubMed ID: 9479343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter comparison of manual and automated screening of AutoCyte gynecologic preparations.
    Bishop JW; Kaufman RH; Taylor DA
    Acta Cytol; 1999; 43(1):34-8. PubMed ID: 9987448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of automated primary screening on liquid-based, thin-layer preparations.
    Vassilakos P; Carrel S; Petignat P; Boulvain M; Campana A
    Acta Cytol; 2002; 46(2):291-5. PubMed ID: 11917575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: II. Prospective and archival sensitivity studies.
    Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
    Cancer; 1997 Dec; 81(6):343-7. PubMed ID: 9438459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: I. A prospective intended use study.
    Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
    Cancer; 1997 Dec; 81(6):337-42. PubMed ID: 9438458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AutoCyte Interactive Screening System. Experience at a university hospital cytology laboratory.
    Howell LP; Belk T; Agdigos R; Davis R; Lowe J
    Acta Cytol; 1999; 43(1):58-64. PubMed ID: 9987451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAPNET for cervical cytology screening. Experience in Greece.
    Veneti S; Papaefthimiou M; Symiakaki H; Ioannidou-Mouzaka L
    Acta Cytol; 1999; 43(1):30-3. PubMed ID: 9987447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AutoPap 300 QC system scoring of cervical smears without "epithelial cell abnormalities".
    Colgan TJ; Bon N; Lee JS; Patten SF
    Acta Cytol; 1997; 41(1):45-9. PubMed ID: 9022725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the utility and effectiveness of the NeoPath AutoPap 300 QC System used routinely.
    Fetterman B; Pawlick G; Koo H; Hartinger J; Gilbert C; Connell S
    Acta Cytol; 1999; 43(1):13-22. PubMed ID: 9987444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of AutoPap system-assisted and manual cytologic screening. A comparison.
    Wertlake P
    J Reprod Med; 1999 Jan; 44(1):11-7. PubMed ID: 9987733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved quality-control detection of false-negative Pap smears using the Autopap 300 QC system.
    Marshall CJ; Rowe L; Bentz JS
    Diagn Cytopathol; 1999 Mar; 20(3):170-4. PubMed ID: 10086244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity studies of AutoPap System Location-Guided Screening of cervical-vaginal cytologic smears.
    Huang TW; Lin TS; Lee JS
    Acta Cytol; 1999; 43(3):363-8. PubMed ID: 10349363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The primary screening clinical trials of the TriPath AutoPap System.
    Wilbur DC; Norton MK
    Epidemiology; 2002 May; 13 Suppl 3():S30-3. PubMed ID: 12071481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective validation of the FocalPoint GS slide profiler NFR technology by analysis of interval disease outcomes compared with manual cytology.
    Nuttall DS; Hillier S; Clayton HR; Savage AJ; Martin CM; O'Leary JJ
    Cancer Cytopathol; 2019 Apr; 127(4):240-246. PubMed ID: 30825407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A feasibility study of the use of the AutoPap screening system as a primary screening and location-guided rescreening device.
    Confortini M; Bonardi L; Bulgaresi P; Cariaggi MP; Cecchini S; Ciatto S; Cipparrone I; Galanti L; Maddau C; Matucci M; Rubeca T; Troni GM; Turco P; Zappa M; Carozzi F
    Cancer; 2003 Jun; 99(3):129-34. PubMed ID: 12811852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of a slide profiler for endocervical cell detection in no-further-review conventional Pap smears.
    Rowe LR; Marshall CJ; Berry M; Larson MA; Bentz JS
    Acta Cytol; 2003; 47(4):602-4. PubMed ID: 12920753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the AutoPap (currently Focalpoint) primary screening system location guide use on interpretation time and diagnosis.
    Ronco G; Vineis C; Montanari G; Orlassino R; Parisio F; Arnaud S; Berardengo E; Fabbrini T; Segnan N
    Cancer; 2003 Apr; 99(2):83-8. PubMed ID: 12704687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.